MOREPENLABUpdated 31 Aug 2026, 13:20

Morepen Lab. Ltd

MOREPENLABUpdated 31 Aug 2026, 13:20

Market Cap

₹5,919Cr.

Current Price

₹108

High / Low

₹110/33.0

Stock P/E

53.2

ROE5.38%

ROCE7.65%

Book Value₹22.7

Face Value₹2.00

Dividend Yield0.19%

About

Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	48	65	55	72	62	56	51	56	70	75	69	72
Inventory Days	56	53	68	79	71	93	84	95	85	85	107	53
Days Payable	124	140	126	176	123	111	95	80	86	103	127	81
Cash Conversion Cycle	-21	-22	-3	-25	10	38	40	71	69	57	50	44
Working Capital Days	-18	-6	-91	-66	-35	-9	16	58	105	104	122	155
ROCE %	2%	8%	8%	8%	8%	9%	21%	22%	9%	18%	13%	8%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 13:20

MOREPEN LAB. LTD (MOREPENLAB) financials — quarterly results, P&L, cash flow, balance sheet, shareholding